Clinical Trials in Austin, United States
Locations / Austin, United States
Delta Trials hosts 118 clinical trials conducted in Austin, United States, making it a notable site of clinical research activity. These trials covering 420 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 2 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Austin.
118
Total Trials
420
Conditions
2
Terminated since 2020
Browse by condition (420 total)
- Advanced malignant solid neoplasm 6 trialsAll Advanced malignant solid neoplasm trials
- Multiple myeloma 4 trialsAll Multiple myeloma trials
- Metastatic malignant solid neoplasm 4 trialsAll Metastatic malignant solid neoplasm trials
- Recurrent malignant solid neoplasm 3 trialsAll Recurrent malignant solid neoplasm trials
- All Unresectable malignant solid neoplasm trials
- All Recurrent langerhans cell histiocytosis trials
- Low grade glioma 3 trialsAll Low grade glioma trials
- Malignant glioma 3 trialsAll Malignant glioma trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- All Refractory langerhans cell histiocytosis trials
- B acute lymphoblastic leukemia 3 trialsAll B acute lymphoblastic leukemia trials
- Refractory malignant solid neoplasm 3 trialsAll Refractory malignant solid neoplasm trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- All Non-muscle invasive bladder neoplasms trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- Stereotypical prolonged seizures 2 trialsAll Stereotypical prolonged seizures trials
- Recurrent neuroblastoma 2 trialsAll Recurrent neuroblastoma trials
- Recurrent malignant germ cell tumor 2 trialsAll Recurrent malignant germ cell tumor trials
- Refractory neuroblastoma 2 trialsAll Refractory neuroblastoma trials
- Recurrent glioma 2 trialsAll Recurrent glioma trials